trending Market Intelligence /marketintelligence/en/news-insights/trending/BVzkYPt8As1Oos9h0h0iYw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Axovant Sciences to raise $40M via common stock offering

Blog

M&A rebound sparks optimism for near-term deal activity

Blog

Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection

Blog

Banking Essentials Newsletter - February Edition

Blog

Message in a (Word)Cloud


Axovant Sciences to raise $40M via common stock offering

Axovant Sciences Ltd. is planning to raise $40 million in gross proceeds through an underwritten offering of common shares.

The London-based developer of neurological and psychiatric treatments plans to issue 26,666,667 common shares for $1.50 per share as part of the offering.

Axovant Sciences also granted underwriters an option to buy up to an additional 4 million common shares. The offering is expected to close March 18.

Jefferies LLC and Guggenheim Securities LLC are acting as underwriters for the offering.